| Price | Lot Size | Issue Date | Issue Size |
|---|---|---|---|
| ₹560 to ₹590 | 25 | 29th July, 2026 – 31st July, 2026 | ₹9275 Cr |
Manipal Health Enterprises Limited
Incorporated in 2010, Manipal Health Enterprises Limited is one of India’s largest integrated multi-specialty hospital chains, providing tertiary and quaternary healthcare services across a diversified network of hospitals, clinics, diagnostic centres and digital healthcare platforms. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories, making it the largest private multispecialty hospital network in India by bed capacity and the second-largest by number of hospitals. The company has established leadership positions across key healthcare markets, particularly in Karnataka, Maharashtra & Goa, and Eastern India (West Bengal, Odisha, Jharkhand and Sikkim). It is the only private hospital chain with market leadership across the three major metropolitan cities of Bengaluru, Kolkata and Pune. Its diversified network is supported by a comprehensive portfolio of clinical specialties, with a strategic focus on high-acuity and complex medical procedures across oncology, cardiology, neurosciences, organ transplantation, orthopaedics, nephrology and critical care. The company follows an integrated healthcare delivery model encompassing hospitals, outpatient clinics, diagnostics, pharmacies, telemedicine and digital health solutions. In addition to its hospital network, it operates 21 clinics, diagnostic services across 18 states under the ManipalTRUtest brand and an expanding digital healthcare ecosystem comprising teleconsultation, AI-enabled patient engagement platforms and e-pharmacy services. The company combines owned hospitals with asset-light operation & management (O&M) hospitals, enabling efficient capital allocation and wider geographical reach.
Objective of Manipal Health Enterprises Limited
The IPO comprises a Fresh Issue and an Offer for Sale (OFS). The Company will not receive any proceeds from the OFS, as the entire proceeds will accrue to the Selling Shareholders. The net proceeds from the Fresh Issue are proposed to be utilized for the following purposes:
- Repayment/prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiary, Manipal Hospitals Private Limited.;
- Acquisition of minority stake in its step-down subsidiary, Sahyadri Hospitals Private Limited.; and
- General corporate purposes.
Rationale To Manipal Health Enterprises Limited
Investment Rationale
Industry-leading integrated healthcare platform with diversified Pan-India presence and strong execution track record
Manipal Health has established itself as one of India’s leading private healthcare providers with a diversified network of 49 hospitals comprising 13,037 licensed beds across 14 states and union territories, making it the largest private multi-specialty hospital chain in India by bed capacity. The company enjoys strong market leadership across Karnataka, Maharashtra & Goa, and Eastern India, while maintaining dominant positions in key metropolitan markets, including Bengaluru, Kolkata, and Pune. Its extensive geographical footprint, coupled with a comprehensive portfolio of tertiary and quaternary care specialties, provides significant competitive advantages through stronger referral networks, higher patient inflows, stronger doctor relationships, and improved pricing power. The company has consistently increased the contribution of high-acuity specialties such as oncology, organ transplantation, neurosciences, cardiology and critical care, which typically generate superior revenue per occupied bed (ARPOB) and support sustainable margin expansion. Further, its integrated healthcare ecosystem, comprising hospitals, outpatient clinics, diagnostics, pharmacies, and digital healthcare platforms, strengthens patient retention, cross-selling opportunities, and long-term revenue visibility. The company’s large operating scale also enables procurement efficiencies, optimized clinical resource utilization and operating leverage, positioning it well to benefit from India’s structurally growing healthcare demand.
A widely recognized brand and robust clinician ecosystem strengthen competitive positioning
Manipal Health has established one of India’s most trusted healthcare brands, supported by a long-standing track record of clinical excellence, superior patient outcomes and strong brand recognition across key healthcare markets. The company’s flagship Manipal Hospital, Old Airport Road, has consistently been ranked as Bengaluru’s leading hospital for nearly two decades, while several hospitals within its network continue to feature among India’s top multi-specialty hospitals. The strong brand franchise has translated into a growing patient base, with the company serving approximately 6.3 million patients in FY26 (pro forma), reflecting increasing acceptance across tertiary and quaternary care services. A well-established brand, coupled with strong referral networks and clinical expertise, supports higher patient volumes, improved occupancy and greater contribution from high-value specialty procedures. The company has also built a strong clinician-led ecosystem with over 11,000 doctors, 11,000 nurses and 6,300+ paramedical professionals, supported by continuous investments in medical education, research and structured training programs. Its long-standing association with the Manipal Academy of Higher Education (MAHE), along with DNB, DrNB and Fellowship programs, enables a sustainable pipeline of skilled medical professionals while strengthening doctor retention and clinical leadership. Furthermore, its patient-centric approach, standardized treatment protocols, and digital healthcare initiatives enhance service quality and the patient experience. We believe the company’s strong brand equity, extensive clinical talent pool, and academic ecosystem create significant barriers to entry, reinforcing its leadership position and supporting sustainable long-term growth.
Valuation of Manipal Health Enterprises Limited
Manipal Health Enterprises is one of India’s leading integrated healthcare providers with a diversified portfolio of multi-specialty hospitals offering tertiary and quaternary care services across key metropolitan and regional markets. Its leadership across Karnataka, Maharashtra & Goa and Eastern India, coupled with a well-diversified specialty mix and strong brand equity, provides a sustainable competitive advantage and positions the company to benefit from rising demand for quality healthcare services. The company has built a strong Pan-India healthcare franchise, supported by complementary businesses including diagnostics, outpatient clinics, pharmacies and digital healthcare services. The long-term outlook for the Indian healthcare industry remains favorable, driven by increasing healthcare awareness, rising health insurance penetration, an ageing population, a higher incidence of lifestyle-related diseases, improving affordability, and growing demand for tertiary and quaternary care. On the financial front, the company has demonstrated a strong growth trajectory, with Revenue/EBITDA/PAT registering CAGRs of 29.4%/24.6%/31.1%, respectively, during FY24-FY26, supported by robust patient volume growth, improving occupancy levels, increasing contribution from high-acuity specialties, and the successful integration of acquired hospitals. The company’s strong operating cash flows, improving profitability and focus on operational efficiencies provide a solid foundation for sustainable earnings growth. As we advance, management remains focused on expanding its hospital network through a balanced strategy of brownfield expansion, greenfield developments and selective acquisitions. The planned addition of nearly 2,400 licensed beds by FY30, coupled with continued investments in digital healthcare, advanced medical technologies and clinician development, is expected to strengthen its market leadership. Furthermore, its integrated healthcare ecosystem, strong clinician network, established referral base, and scalable operating model create significant barriers to entry and enhance long-term growth visibility. At the upper price band of Rs. 590, the issue is valued at a P/E of 76.9x based on annualized FY26 earnings on a post issue basis. We thus, recommend a “SUBSCRIBE” rating from a medium to long-term perspective.
What is the Manipal Health Enterprises Limited IPO?
The initial public offer (IPO) of Manipal Health Enterprises Limited offers an early investment opportunity in. A stock market investor can buy Manipal Health Enterprises Limited IPO shares by applying in IPO before All Manipal Health Enterprises Limited shares get listed at the stock exchanges. An investor could invest in Manipal Health Enterprises Limited for short term listing gain or a long term.
How to apply for the Manipal Health Enterprises Limited IPO through StoxBox?
To apply for the Manipal Health Enterprises Limited IPO through StoxBox one can apply from the website and also from the app. Click here
When will the Manipal Health Enterprises Limited IPO open?
Manipal Health Enterprises Limited IPO is opening on 29th July 2026. Apply Now
What is the lot size of the Manipal Health Enterprises Limited IPO?
The Lot Size of Manipal Health Enterprises Limited 25 equity shares. Login to your account now.
When is the Manipal Health Enterprises Limited IPO allotment date?
The allotment Date for Manipal Health Enterprises Limited IPO is 03rd Aug 2026. Login to your account now.
When is the Manipal Health Enterprises Limited IPO listing date?
The listing Date for Manipal Health Enterprises Limited is 05th Aug 2026. Login to your account now
What is the minimum investment required for the Manipal Health Enterprises Limited IPO?
In the Retail segment the minimum investment required is Rs 14,750 Login to your account now
What is the maximum investment allowed for Manipal Health Enterprises Limited IPO?
In the Retail segment the maximum investment requirement Rs 1,91,750 Login to your account now
What are the risks associated with investing in the Manipal Health Enterprises Limited IPO?
- The company’s growth strategy is highly dependent on the successful integration of acquired hospitals, and any delay in realizing operational synergies could adversely affect financial performance.
- Expansion plans require substantial capital expenditure and execution capabilities, and any delay in commissioning new hospitals or achieving targeted occupancy levels may impact return ratios and earnings growth.
- The business depends on attracting and retaining experienced doctors, surgeons, and medical professionals, and an inability to maintain strong clinical talent could adversely affect patient volumes and service quality.
When will the Manipal Health Enterprises Limited IPO shares be credited to my Demat account?
The Manipal Health Enterprises Limited will be credited to the account on allotment date which is 03rd Aug 2026. Login to your account now
Where can I find the Manipal Health Enterprises Limited IPO prospectus?
The prospectus of Manipal Health Enterprises Limited IPO prospectus can be found on the website of SEBI, NSE and BSE
